Fennec Pharmaceuticals Inc. (FENC): Price and Financial Metrics


Fennec Pharmaceuticals Inc. (FENC)

Today's Latest Price: $5.73 USD

0.05 (-0.87%)

Updated Sep 25 4:00pm

Add FENC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

FENC Daily Price Range
FENC 52-Week Price Range

FENC Stock Price Chart Technical Analysis Charts


FENC Price/Volume Stats

Current price $5.73 52-week high $10.67
Prev. close $5.78 52-week low $4.20
Day low $5.64 Volume 138,270
Day high $5.91 Avg. volume 236,497
50-day MA $6.81 Dividend yield N/A
200-day MA $6.96 Market Cap 147.89M

Fennec Pharmaceuticals Inc. (FENC) Company Bio


Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, a water soluble thiol compound that acts as a chemical reducing agent, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was founded in 1996 and is based in Research Triangle Park, North Carolina.


FENC Latest News Stream


Event/Time News Detail
Loading, please wait...

FENC Latest Social Stream


Loading social stream, please wait...

View Full FENC Social Stream

Latest FENC News From Around the Web

Below are the latest news stories about Fennec Pharmaceuticals Inc that investors may wish to consider to help them evaluate FENC as an investment opportunity.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENC

New York, New York--(Newsfile Corp. - September 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fennec Pharmaceuticals Inc. ("Fennec") (NASDAQ: FENC) between February 11, 2020 and August 10, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the the United States District Court for the Middle District of North Carolina. To ...

Yahoo | September 24, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / September 24, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Fennec Pharmaceuticals Inc.

Yahoo | September 24, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FSLY, PROG and FENC

NEW YORK, NY / ACCESSWIRE / September 24, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies.

Yahoo | September 24, 2020

DEADLINE ALERT for FENC, POR, HDB, and UPLCQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] Pharmaceuticals Inc. (NASDAQ: FENC) Class Period: February 11, 2020 – August 10, 2020 Lead Plaintiff Deadline: November 2, 2020The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as wel...

Yahoo | September 24, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FENC, COTY and GOCO

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies.

Yahoo | September 24, 2020

Read More 'FENC' Stories Here

FENC Price Returns

1-mo 4.95%
3-mo -29.95%
6-mo -3.54%
1-year 19.38%
3-year -49.29%
5-year N/A
YTD -11.71%
2019 1.72%
2018 -36.33%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6265 seconds.